These findings suggest that CD11c+/Ly6C− cells might promote liver fibrosis and HSC activation, whereas CD11c−/Ly6C+ cells might play an anti-inflammatory role and promote tissue repair, similar to M2 macrophages. This evidence concerns the gene ITGAX and Hepatic fibrosis.